Contract · Federal · No Set aside used
Specialized Blood Products-AABB
- Agency
- HEALTH AND HUMAN SERVICES, DEPARTMENT OF / NATIONAL INSTITUTES OF HEALTH
- Location
- Bethesda, MD
- Amount
- Amount not listed
- Posted
- Sep 10, 2026
- Set-aside
- No Set aside used
- NAICS code
- 621991 - Blood and Organ Banks look up NAICS codes
- PSC code
- 6505
Timeline
-
Posted
Sep 10, 2026
-
Status
Closing soon
What contracts like this typically pay
No award history yet for this category (NAICS 621991).
What this contract is for
- Agency
- HEALTH AND HUMAN SERVICES, DEPARTMENT OF / NATIONAL INSTITUTES OF HEALTH
- Location
- Bethesda, MD
- Set-aside
- No Set aside used
- NAICS
- 621991 - Blood and Organ Banks
- Scope
- Federal
The National Institutes of Health (NIH), Clinical Center (CC), Office of Purchasing and Contracts, on behalf of the Department of Transfusion Medicine (DTM), Transfusion Services Laboratory (TSL), intends to award a sole-source Indefinite Delivery/Indefinite Quantity (IDIQ) contract to the National Blood Exchange (NBE), Association for the Advancement of Blood & Biotherapies (AABB) for the provision of specialized blood products, including rare blood types, required to support patient care within the NIH Clinical Center.
The NIH Clinical Center is a 200-bed research hospital that provides care to patients participating in NIH research protocols.
The Department of Transfusion Medicine requires specialized blood products for patients requiring transfusion therapy, including rare red blood cells (RBCs), platelets, and plasma products.
The contractor shall be capable of providing specialized blood products, including leukoreduced red blood cells, AB plasma, cryoprecipitate, and single-donor platelets.
The requirement includes rare, multiple-antigen-negative RBC products for sickle cell disease and other multiply transfused patients.
Required blood products must be prepared in accordance with applicable Association for the Advancement of Blood and Biotherapies (AABB), College of American Pathologists (CAP), Clinical Laboratory Improvement Amendments (CLIA), and Food and Drug Administration (FDA) requirements and must be screened and certified for human use.
The contractor must also be capable of providing antigen-screened units for common and uncommon RBC antigens, including, but not limited to, C, E, K, k, Fy(a), Fy(b), S, s, Jk(a), Jk(b), V/VS, Go(a), Js(a), and U.
The anticipated annual requirement includes approximately 300–400 antigen-negative leukoreduced red blood cells, 50–...
Official solicitation and documents
The full solicitation, any attachments, and the actual submission instructions live on the official listing, not on this page. Oppward summarizes public record data; it does not host or mirror the source documents.
Oppward is an independent service and is not affiliated with, endorsed by, or sponsored by SAM.gov or any government agency. This page is a plain-English summary of public record data; the linked source above is the authoritative listing.
How to bid on this
This is a contract solicitation, not a grant. To bid, you submit a proposal (usually a price and a description of how you would do the work) directly to the government, through the channel the official listing specifies, not through Oppward.
- Make sure your business has an active SAM.gov registration. You cannot be paid on a federal contract without one.
- Read the full solicitation on the official listing above, especially the scope of work, not just this summary. Our guide to reading a solicitation walks through what to look for.
- Check the set-aside listed above and confirm your business actually qualifies for it before you spend time on a proposal. See our guide to set-asides if the category is unfamiliar.
- Submit your proposal by the deadline, using the exact submission method the official listing states. A technically on-time bid sent the wrong way is often treated as late.
Get contracts like this one matched to your business, free.